Understanding of the costs of drug-related actions is an important aspect of drug policy.
In Slovakia, drug policy documents have no associated budgets and estimates of the total executed expenditures are not made on a regular basis. One study estimated that total drug-related public expenditure represented 0.05 % of gross domestic product, or EUR 21.3 million, in 2006. Around 70 % of total public expenditure was allocated to public order and safety, while the rest was allocated to treatment, prevention, coordination, education and harm reduction.
The available information does not allow trends in drug-related public expenditures in Slovakia to be reported.